University of Missouri scientists are partnering with Harvard and Georgia Tech to create a new diabetes treatment that involves transplanting insulin-producing pancreatic cells. Type 1 diabetes is estimated to affect around 1.8 million Americans. Although type 1 diabetes often develops in childhood or adolescence, it can occur in adulthood…
Circa 2020
You’ve no doubt heard of the Large Hadron Collider (LHC), the massive particle accelerator straddling the border between France and Switzerland. The large size of this instrument allows scientists to do cutting-edge research, but particle accelerators could be useful in many fields if they weren’t so huge. The age of room-sized (and larger) colliders may be coming to an end now that researchers from Stanford have developed a nano-scale particle accelerator that fits on a single silicon chip.
Full-sized accelerators like the LHC push beams of particles to extremely high speeds, allowing scientists to study the minutiae of the universe when two particles collide. The longer the beamline, the higher the maximum speed. Keeping these beams confined requires extremely powerful magnets, as well. It all adds up to a bulky piece of equipment that isn’t practical for most applications. For example, cancer radiation treatments with a particle accelerator could be much safer and more effective than traditional methods.
Continue reading “Researchers Create Particle Accelerator on a Chip” »
Circa 2019
Thanks to research led by Cornell AgriTech’s David Gadoury, farmers may no longer have to rely on fungicides to control powdery mildew, a rampant plant fungal disease.
Tel Aviv University researchers have published a new study in Nature outlining how a type of white blood cell can be engineered to secrete anti-human immunodeficiency virus (HIV) antibodies. Based on the results of this study, the team are hopeful that they will be able to produce a one-time medication for acquired immune deficiency syndrome (AIDS) and other diseases.
Gene therapy for HIV
The introduction of treatments such as anti-retroviral therapy (ART) for HIV has helped patients diagnosed with the infection to live longer and healthier lives. Patients are required to take the medicine daily in order to reduce the amount of virus in the body (viral load) so that it is undetectable. If a viral load is undetectable, patients with HIV have effectively zero risk of transmitting the virus. However, a one-time treatment for HIV, which can develop into AIDS, is still desirable to improve HIV patients’ quality of life.
A new mechanism that causes cardiac hypertrophy – one of the major drivers of heart disease – has been identified, potentially enabling new treatments to be developed.
8,000+ Films, Shows & Classes on Gaia. Start Your Free Trial — https://bit.ly/3eBA6jy.
Can AI enable us to live forever? In A.rtificial I.mmortality, filmmaker Ann Shin sets out on a journey, exploring the latest AI and biotech with scientists and visionaries who foresee a ‘post-biological’ world where humans and AI merge. Will AI be the best, or the last thing we ever do?
Ken OtwellIt’s an awkward situation. Was the engineer continuing to do his job? Was his public claim about internal corporate technology interfering with his duties or causing harm to Google? Was it breaking a voluntary non-disclosure?
Kevin CuevasWith neurocyte based computing, it is a question worth exploring since we are already blurring that line anyway.
Continue reading “Growing Human Neurons Connected to a Computer” »
In cancer, healthy cells turn into malignant ones with very different characteristics, such as the ability to divide in an uncontrolled manner. In recent decades, much research has uncovered various molecular alterations responsible for this conversion from healthy to tumor tissue. But until now, scientists have known very little about the opposite process – reversing a cancer cell, turning it into a physiological, noncancerous one, and what factors might mediate this process.
“We know that one strategy that human tumors have to dodge the effectiveness of drugs is to change their appearance, becoming another similar cancer but insensitive to the drug used,” the team said. “For example, leukemias of the lymphoid lineage are switched to the myeloid strain to escape treatment.”
With this idea in mind, they wanted to know more about the molecular pathways involved in this cellular transformation. They studied an in vitro model (experiment performed outside of a living organism, usually in a test tube or petri dish) in which leukemia cells can be forced to turn into a type of harmless immune cells called macrophages.
Cancer, in the simplest terms, is the transformation of normal cells into malignant ones that grow and divide uncontrollably. It, however, is not one disease but a group of more than 100 different and distinctive diseases, and leukemia, or blood cancer, is just one of them. Leukemia begins in…
David Sinclair shares another side of himself. Compassion for all people. He wants to make sure that longevity technologies are available for all people, not just for the super wealthy and their pets. He also speaks of emerging elderly populations who can live well up until death rather than suffering for so long, and instead start new careers and hobbies.
Researchers have restored vision in animal by resetting some of the thousands of chemical marks that accumulate on DNA as cells age. The work, by Dr David Sinclair Lab, published in Nature Dec 2020, suggests a new approach to reversing age-related decline, by reprogramming some cells to a ‘younger’ state in which they are better able to repair or replace damaged tissue.
